BCAR1 up regulation was linked to aggressive cancer features in our study, including high Gleason score, advanced tumor stage, presence of lymph node metastases, rapid tumor cell proliferation and early biochemical recurrence, arguing for a contribution of elevated BCAR1 protein expression to prostate cancer progression. This evidence concerns the gene BCAR1 and prostate cancer.